Neuroprotective dose and safety profile of magnesium sulphate therapy in term neonates with perinatal asphyxia

Abstract

Introduction: Perinatal asphyxia has become a major public health problem accounting for 9% of total under-5 mortality. It can lead to serious neuro-motor sequelae in survivors. Newer neuroprotective strategies for management of perinatal asphyxia have gained momentum in recent era. Background: To determine the effective dosage regimen and safety profile of intravenous magnesium sulphate as a neuroprotective agent for perinatal asphyxia in term neonates. Materials and methods: 60 term asphyxiated neonates admitted in NICU of a tertiary care teaching hospital were evaluated. Babies were treated as per the standard treatment protocol for perinatal asphyxia. The infants received 250 mg/kg per dose intravenous magnesium over 1 hour within 6 hrs of birth, with 2 additional doses repeated at intervals of 24 hours. The heart rate, respiratory rate, blood pressure and oxygen saturation were monitored continuously. A baseline serum magnesium level was measured soon after delivery and two more serum magnesium levels at 24 hr and at 48 hr was measured. Results: The pre intervention baseline serum magnesium level was 1.52 (±0.302) meq/L. The serum magnesium level increased from the baseline level of 1.52 (±0.302) meq/L to 2.63 (±0.558) meq/L at 24 hour and 2.72 (±0.495) meq/L at 48 hour. The neuroprotective range of serum magnesium is 2.4 – 5 Meq/L. This dosage regimen will ensure plasma concentration of magnesium in the neuroprotective range for 48 hours. All physiologic variables remained unchanged including heart rate, respiratory rate, blood pressure and oxygen saturation during intervention. Conclusion: Intravenous infusion of 3 doses of magnesium 250 mg/kg/dose in first 48 hrs after birth will ensure serum magnesium level in the neuroprotective range. This therapeutic dosage regimen has been found to have the best margin of safety profile in term asphyxiated infants.

Authors and Affiliations

Raj Prakash

Keywords

Related Articles

Prevalence of anemia and its etiology: a study in a semi urban area

Introduction: Anemia is recognized as a public health problem throughout the world affecting both developed and developing countries and is associated with nutritional deficiencies especially due to iron deficiency, whic...

Association of BMI, socioeconomic status and menarche age with anemia in rural school going adolescent girls

Background: India has the world’s highest prevalence of anemia among women and adolescent girls. Rural adolescent girls are particularly vulnerable to develop anemia.Aims and Objectives: To study the prevalence of anemia...

A study on evaluation of waist height ratio as a screening tool for obesity

Introduction: Childhood obesity has become a single marker for children at risk for development of various noncommunicable diseases later in life. This study is conducted to estimate the prevalence of obesity and the ris...

Spectrum of Pediatric Dermatoses in The Pediatric Outpatient Clinic of a Rural Teaching Hospital

Introduction: Skin diseases in the pediatric population are common all over the world including rural and urban areas. There is variation in the pattern and presentation of Dermatoses, with eczemas being the most common...

Correlation between NT pro-b-type Natriuretic peptide and left ventricular ejection fraction in children presenting with Dyspnea– a prospective cohort study

Introduction: Simple screening tests exist for congenital heart diseases but the same cannot be said for cardiac failure in children. Although echocardiography is considered the gold standard for the detection of left ve...

Download PDF file
  • EP ID EP223340
  • DOI 10.17511
  • Views 180
  • Downloads 0

How To Cite

Raj Prakash (2016). Neuroprotective dose and safety profile of magnesium sulphate therapy in term neonates with perinatal asphyxia. Pediatric Review: International Journal of Pediatric Research, 3(2), 119-123. https://europub.co.uk/articles/-A-223340